MRX001 Blister Multidose DPI
MRX001 is a blister based multidose dry powder inhaler (DPI). MRX001 is based on the open-click-inhale-close principle and can be used as a generic device...
EXPLORE MRX001
Merxin is active in the fields of pharmaceuticals, cannabinoid therapies (inhaled cannabinoid therapies iCTx) and reduced risk nicotine inhalers (RiNih).
MRX001 is a blister based multidose dry powder inhaler (DPI). MRX001 is based on the open-click-inhale-close principle and can be used as a generic device...
EXPLORE MRX001
MRX002 is a PET vial ideal for modelling pMDI formulations. MRX002 is a clear vial that can be fitted with commercial pMDI valves, continuous and...
EXPLORE MRX002
MRX003 is a generic capsule based inhaler designed in particular as a generic AB rated device for tiotropium DPI.
It is developed for new molecules and the...
EXPLORE MRX003
MRX004 is a soft mist inhaler device. It is developed as an interchangeable AB rated device opportunity for tiotropium/olodaterol as formulated with the Respimat.
MRX004 is...
EXPLORE MRX004
Dual cavity for triple therapy dry powder inhaler (DPI). MRX006 is based on the open-inhale-close principle. It is suitable as an AB-rated substitutable device for triple combination...
EXPLORE MRX006
Merxin has partnered with Perlen to take the BLISTair DPI technology to the iCTx markets (inhaled cannabinoid therapies).
The PERLAMED™ BLISTair is a single-use inhaler...
EXPLORE BLISTair ICTX